Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
RecruitingNCT07166289Phase: NAStarted 2025-09-30
Summary
Approximately one third of individuals with Major Depressive Disorder (MDD) are considered treatment-resistant, subject to severe disability and risk of suicide, and exhibit symptoms anchored in abnor
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Laureate Institute for Brain ResearchTulsa, Oklahoma, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07166289